Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Magma Fincorp 10.9 14.5 15.4 11.5 100 116 1.7 1.4 Kushan Parikh
Mahindra Finance 21.2 28.7 23.0 17.0 150 173 3.3 2.8 kushan.parikh@emkayglobal.com
+91-22-266242431
Shriram City Union Fin 128.6 162.4 18.0 14.2 858 972 2.7 2.4
Shriram Transport Fin 105.4 129.7 13.9 11.3 568 671 2.6 2.2
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Index
Margin compression gradual, not instant ...................................................................... 3
Companies
Bajaj Finance ..............................................................................................................18
HDFC ..........................................................................................................................31
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
On the contrary, we are of the opinion that the gradual tightening of policy rates by RBI
would bring about a level-playing field for NBFCs.
With each REPO hike, the cost of funds for Banks would also start rising, in line with NBFCs that
anyhow had been facing the heat due to rising bond yields. Thus, with the REPO hike, Banks
and NBFCs would be on an even keel. We explain this further as follows.
Exhibit 1: Rise in REPO is generally followed by rise in Term Deposit rates, making overall cost of funds more expensive for banks
11.0
10.0
9.0
8.0
7.0
6.0
5.0
4.0
01-04-2002
01-10-2009
01-08-2015
01-06-2016
01-02-2018
01-09-2002
01-02-2003
01-07-2003
01-12-2003
01-05-2004
01-10-2004
01-03-2005
01-08-2005
01-01-2006
01-06-2006
01-11-2006
01-04-2007
01-09-2007
01-02-2008
01-07-2008
01-12-2008
01-05-2009
01-03-2010
01-08-2010
01-01-2011
01-06-2011
01-11-2011
01-04-2012
01-09-2012
01-02-2013
01-07-2013
01-12-2013
01-05-2014
01-10-2014
01-03-2015
01-01-2016
01-11-2016
01-04-2017
01-09-2017
Repo Rate SBI 1yr TD Rate SBI 3yr TD Rate
Exhibit 2: Historically, with the beginning of monetary tightening cycle, bond yields have remained stagnant
12.0
11.0
10.0
9.0
8.0
7.0
6.0
5.0
4.0
01-04-2002
01-10-2009
01-08-2015
01-06-2016
01-02-2018
01-09-2002
01-02-2003
01-07-2003
01-12-2003
01-05-2004
01-10-2004
01-03-2005
01-08-2005
01-01-2006
01-06-2006
01-11-2006
01-04-2007
01-09-2007
01-02-2008
01-07-2008
01-12-2008
01-05-2009
01-03-2010
01-08-2010
01-01-2011
01-06-2011
01-11-2011
01-04-2012
01-09-2012
01-02-2013
01-07-2013
01-12-2013
01-05-2014
01-10-2014
01-03-2015
01-01-2016
01-11-2016
01-04-2017
01-09-2017
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Exhibit 3: As bank’s raise lending rates, NBFCs switch to bank borrowings to cap overall cost of borrowings for a longer tenure
100% 9.0
15%
16%
18%
18%
18%
20%
20%
22%
22%
22%
90% 8.5
80% 8.0
70% 7.5
42%
48%
43%
43%
45%
48%
60% 7.0
50%
52%
52%
57%
50% 6.5
40% 6.0
30% 5.5
42%
39%
39%
37%
37%
32%
20% 5.0
30%
26%
26%
20%
10% 4.5
0% 4.0
FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
100% 4%
7% 18% 23%
80% 15%
70% 70% 20% 61%
60% 73%
30% 88%
56% 100% 95%
40%
58%
20% 44% 18% 39%
25% 23% 30%
12% 13% 5%
0% 3%
BAF SCUF SHTF CIFC MMFS MGMA HDFC LICHF LTFH EDEL
Consumer Finance/Retail Lending SME Business / Business Finance Commercial/Wholesale Rural Housing / LAP Vehicle Finance
Being product experts, NBFCs are always able to price their risks appropriately with sufficient
space for any probable loss or delinquencies. This also makes them price makers and allows
them to command desired pricing. The recent hike by HDFC Limited for its housing finance
products also underscores HFCs’ ability to pass on cost pressures to the end customers.
Major price disruptors are already out of the game for now
Since a key target area for most NBFCs has been Rural/Semi Urban areas, the main competitor
for most of them had been mid-sized regional PSBs and other NBFCs and not large PSBs/Private
Banks. PSBs have been instrumental in being the price disruptors in order to gain market share
where NBFCs used to enjoy almost a monopoly position.
However, there had been several instances whereby these PSBs failed to price the risks
associated with a particular product appropriately, resulting in large delinquencies in a particular
segment. This not only impacted the particular PSB, but also other players in that space.
Exhibit 6: List of 11 PSBs under PCA Exhibit 7: Market share in lending for PSBs under PCA is falling
rapidly – This is surely advantageous for NBFCs
Allahabad Bank IDBI Bank PCA Banks advances as a % of total SCBs advances
Bank of India Indian Overseas Bank
27% 26% 26% 26% 26% 26%
Bank of Maharashtra Oriental Bank of Commerce 25% 25% 24%
25%
Central Bank of India UCO Bank 22%
23%
Corporation Bank United Bank of India 21% 20%
Dena Bank 19%
Source: Company, Emkay Research 17%
15%
FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17
With many of the regional PSBs already under RBI’s PCA, they are technically unable to lend
incrementally. This further benefits NBFCs not only on the growth front but also on the pricing
front since competition from major price disruptors has diminished.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Exhibit 8: Top HFCs borrowing maturity profile – ex HDFC Exhibit 9: Top HFCs lending maturity profile – ex HDFC
100% 100%
27% 24% 23% 22% 24%
80% 80%
60% 59% 60% 55% 52%
21% 21% 24% 24% 22% 60%
60%
As of March’17, ~22% of HFCs liabilities were maturing in under 1 year as opposed to ~11% of
their lending books maturing in less than 1 year. Similarly, ~54% of overall borrowings are
expected to mature within 3 years from March’17 as against ~31% asset book maturities.
Although on a downward trajectory on a yoy basis, the proportion of longer tenure lending (more
than 5 years) is still elevated at ~52% against ~24% for maturity of liability.
Exhibit 10: AFCs – Borrowings incl. deposits Exhibit 11: AFCs – Advances
100% 7% 7% 100%
9% 8% 9% 13% 13% 10% 10% 9%
7% 8% 13% 16% 15% 10% 13% 13%
80% 80% 10% 11%
20% 42% 44% 38% 20% 33% 34% 40% 38% 38%
32% 34%
0% 0%
FY13 FY14 FY15 FY16 FY17 FY13 FY14 FY15 FY16 FY17
Upto 1 year Over 1 year to 3 years Upto 1 year Over 1 year to 3 years
Over 3 to 5 years Over 5 years Over 3 to 5 years Over 5 years
Source: Company, Emkay Research Source: Company, Emkay Research
Note: AFCs incl. BAF, CIFC, MGMA, MMFS, SHTF.
All AFCs under our coverage universe have well balanced ALM profile, which is making them
less vulnerable to the gradually tightening monetary policy. This further reinforces our preference
for AFCs over HFCs, as probability of healthier margins is higher in AFCs vis-à-vis HFCs.
Although AFCs, especially Vehicle Finance companies, have a higher proportion of fixed rate
loans, with faster churn and favorable ALM profile, the impact on margins would be fairly limited.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
We also believe that markets’ concerns about margin pressure are little exaggerated. The
enhanced pricing power of NBFCs in recent times, along with their better liability management
capabilities may support spreads/margins in FY19.
13.6%
13.5%
13.2%
12.1%
11.7%
11.4%
16%
14%
8.4%
8.3%
8.2%
8.1%
8.1%
8.1%
12%
8.0%
7.9%
7.8%
7.7%
7.6%
7.5%
7.5%
7.5%
7.3%
6.6%
6.5%
6.4%
10%
8%
3.3%
3.2%
3.2%
2.5%
2.5%
6% 2.4%
4%
2%
0%
BAF CIFC EDEL HDFC LICHF LTFH MGMA MMFS SCUF SHTF
10.9%
10.6%
10.4%
10.2%
9.4%
9.4%
12%
8.8%
8.2%
8.1%
7.9%
7.6%
7.6%
7.5%
10%
6.0%
5.9%
5.8%
5.7%
5.7%
5.6%
5.4%
5.4%
5.2%
5.1%
8%
4.8%
6%
2.4%
2.3%
2.3%
1.2%
1.1%
1.1%
4%
2%
0%
BAF CIFC EDEL HDFC LICHF LTFH MGMA MMFS SCUF SHTF
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
700,000
586,307 598,093
600,000
500,000
400,000
300,000
200,000
100,000 67,694
0
FY10 FY16 FY17
However, after analyzing this data further, we observed that at most times, such aggressive
growth in financial inclusion is driven by establishment of business correspondents instead of
building formal bank branches.
Exhibit 15: Banking Outlets in Villages / Rural Locations in FY10 Exhibit 16: Banking Outlets in Villages / Rural Locations in FY17
Total locations - 67,694 Total locations - 598,093
9%
Branches Branches
49%
51%
Business Correspondents Business Correspondents
91%
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Since NBFCs are expanding their footprint aggressively in rural/semi urban areas, they would be
able to notch comfortable and sustainable growth for a long time to come.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
HDFC Bank
15% State Bank of India
16%
ICICI Bank
4% Indusind Bank
4% 12% Shriram Transport
Mahindra Finance
5%
Cholamandalam Finance
6% 8%
Tata Motors Finance
8% 6% Sundaram Finance
Kotak Mahindra Prime
16%
Others
There has been consistent trepidation over the growing presence of Commercial Banks
(especially private banks), which will grab sizeable market share in Vehicle Finance. However,
our analysis suggests that NBFCs are still able to hold their ground in Vehicle Financing against
the rising competition.
100%
80%
51% 50%
60%
40%
49% 50%
20%
0%
FY17 FY18
Banks NBFCs
In past 2 years, 50% of Vehicle Finance business in India has managed by NBFCs and they
faced fairly limited pressure from rising competition. In pure retail lending segments like 2
Wheeler Finance and Car Finance etc, Banks will have an upper hand. However, in CV Finance
and Tractor Finance, NBFCs are able to sustain strong growth momentum.
Although the New CV space has remained competitive with few large and medium sizes private
banks already present there, flexible operations, quicker turnaround times and improved
capability to understand clients’ needs give some edge to the NBFCs.
Used Vehicle (CV/Tractors/Cars) is a key focus area for NBFCs where competition (especially
from Banks) is limited and pricing is superior, mainly due to the risks involved and sticky nature
of the customers.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Exhibit 20: CV Financiers have decent presence in New CV as well as Used CV segments
100%
12%
80%
20%
26% 22%
0% 9%
Cholamandalam Magma Fincorp Mahindra Finance Shriram Transport
Finance
Used vehicle New vehicle
The sustainability of CV demand has always remained questionable considering the volatility in
CV cycle and multiple variables driving the same, like government’s infrastructure spending,
private capex cycle, interest rate environment etc.
However, we remain optimistic about the sustainability of the current CV cycle, considering the
government’s consistent push to increase infrastructure spending, change in emission norms
and implementation of the vehicle scrappage policy by 2020.
Fear of spike in defaults due to steep increase in fuel prices is real. But, freight charges are
typically expected to increase with a lag.
There have been a lot of discomfiture over the recent steep rise in fuel prices and fleet operators’
inability to raise freight charges. However, our analysis of empirical data clearly suggests that
freight charges tend to rise in tandem with fuel prices, but with a lag.
Exhibit 21: Freight rates rise with increase in fuel charges but with some lag
2.4 1.5
2.3 1.4
1.3
2.2
1.2
2.1
1.1
2.0 1.0
1.9 0.9
Jul-14
Jul-15
Jul-16
Jul-17
Nov-15
Sep-17
Jan-18
Nov-13
Jan-14
Sep-14
Jan-16
Sep-16
Mar-14
Nov-14
Jan-15
Sep-15
Mar-15
Mar-16
Nov-16
Jan-17
Mar-17
Nov-17
Mar-18
May-14
May-15
May-16
May-17
Avg freight rate (per km per tonne) Fuel cost (per km per tonne)
Source: Industry, Company, Emkay Research
Hence, we believe that the concerns over rising delinquencies due to the steep rise in fuel prices
and the inability of operators to increase freight charges is overdone. We expect the rise in freight
charges to come thorough soon.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
We remain structurally negative on Mono-line HFCs considering the risk to their overall business
model amid stunted growth and pressure on margins, along with rising competition from private
banks as well as newly formed NBFC-HFCs. However, considering the recent correction in their
stock prices, HFCs can provide an attractive trading opportunity as and when the large banks
announce considerable hike (~25/50bps) in their lending rates (MCLR), as it would allow HFCs
to command better pricing for their current as well as incremental lending.
60%
40%
50%
35%
33%
30%
27%
40%
26%
25%
25%
25%
25%
24%
21%
21%
20%
19%
19%
19%
19%
19%
19%
19%
18%
18%
17%
16%
16%
30%
15%
15%
20%
10%
0%
-10% -3%
BAF CIFC EDEL HDFC LICHF LTFH MGMA MMFS SCUF SHTF
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
NBFCs have flexible lending operations and faster turnaround times. Also, overall understanding
of clients’ profiles is superior and hence NPAs have been contained. Thus, compared to formal
banking channels, NBFCs are much better placed, which further justifies their valuation premium
over Banks (including private banks).
9.2%
1.5%
0.4%
1.7%
1.8%
0.7%
1.1%
0.0%
0.8%
0.4%
4.8%
2.3%
7.0%
8.5%
3.8%
9.0%
3.4%
2.8%
5.2%
20%
0% 0%
BAF CIFC EDEL HDFC LICHF LTFH MGMA MMFS SCUF SHTF
15.7%
16.6%
11.8%
18.4%
11.2%
10.9%
20%
8.4%
8.3%
2.2%
5.5%
5.7%
6.8%
3.4%
1.3%
0.4%
8.8%
4.8%
1.2%
0.5%
1.0%
1.3%
0.6%
7.5%
5% 10%
0% 0%
BOB BOI CBK PNB SBIN UNBK AXSB HDFCB ICICIBC IIB KMB YES
Ind AS is a global accounting practice that NBFCs are mandated to adopt, which may lead to
initial credit losses. The practice is on par with the International Financial Reporting Standard
(IFRS) 9. The provisioning requirements under IFRS 9 would be higher, as NBFCs will have to
provide for expected losses rather than incurred losses.
Although the implementation of Ind AS is uncertain for now, many NBFCs have already started
implementing the same. Since the provisioning charge will differ from rule-based recognition to
Expected Credit Loss (ECL) model, we might see some initial surge in overall credit costs of
NBFCs. However, considering the favourable credit cycle and relatively better underwriting
practices, there is fairly limited probability for major negative surprises on the credit cost front.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
60%
50%
40%
30%
20%
50.4%
20.7%
41.8%
41.3%
40.4%
41.4%
40.3%
39.4%
50.5%
48.6%
39.7%
38.3%
37.4%
39.7%
39.9%
40.2%
21.3%
21.3%
10%
0%
BAF CIFC MGMA MMFS SCUF SHTF
6%
5%
4%
3%
2%
3.7%
5.0%
4.9%
4.7%
3.5%
3.3%
5.1%
4.9%
4.6%
3.3%
3.2%
3.2%
5.1%
5.1%
5.0%
1.8%
1.8%
1.8%
1%
0%
BAF CIFC MGMA MMFS SCUF SHTF
Given the advancement in banking technology, we expect further improvement in these metrics,
which would in turn drive further improvement in return ratios. Manual lending methods are
already being shifted to TAB-based approvals for most consumer-centric lending. Cross-selling
of existing products and generation of fee-based income have also been among the other
emerging trends, which we believe would be additional drivers to improve return ratios.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
On the other hand, HFCs are still seeing muted growth and barring a few companies growth in
the Individual Home Loan segment is clearly sluggish. Incrementally, we are seeing HFCs with
tepid individual home loan growth getting more aggressive in Construction Finance and LAP
segments to drive growth. However, the HFC space is getting more competitive amid the
tightening of policy interest rates by RBI and strengthening of newly formed NBFC-HFCs.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
We continue to prefer Bajaj Finance, Shriram Transport Finance, L&T Finance, Edelweiss
and Magma Fincorp in the NBFC space.
Bajaj Finance: Although investments in geographical expansion and future growth are
expected to keep opex elevated, BAF has consistently clocked superior growth (FY11-18:
41%/40% AUM/PAT CAGR) vis-à-vis peers without compromising on asset quality. We
believe that its foray into Housing Finance and ongoing expansion into Rural geographies
will further reinforce its growth impulses. The stock trades at 5.4x FY20E Adj. BV and 26x
FY20E EPS, for a return profile of average 3.5%+ ROAs / 20%+ ROEs. We maintain BUY
with a TP of Rs2,375.
Shriram Transport Finance: Healthy AUM growth, aided by a favorable CV cycle,
improved demand for Used CVs and reduced credit cost (post 90-day NPA recognition)
make SHTF one of the most preferred stocks in our NBFC coverage universe. The stock
still remains at a comfortable discount to most peers (Cholamandalam, Sundaram etc.),
which according to us should narrow gradually. We recommend BUY with a TP of Rs1,818,
corresponding to ~2.7x P/Adj FY20E book with superior RoA of 2.6% and RoE of 18.5%
for FY20E.
L&T Finance: We believe that LTFH’s successful turnaround of the lending business and
focus on realization of the book will aid in sustainably improving its profitability and return
ratios. Consolidated ROE has improved from 10% in FY16 to ~15% in FY18. Being a
diversified financial services player, LTFH has multiple levers of growth. Moreover, a robust
and sustainable fee income franchise helps it to maintain profitability. We expect this will
enable LTFH to clock consolidated PAT CAGR of 40% over FY18-20E. However, the drag
from the Wholesale business is likely to endure in the near term. Given the favorable risk-
reward on balance, we maintain BUY with a TP of Rs238.
Edelweiss: We believe that the company would continue to pursue aggressive growth in
superior RoE businesses, which in turn will result in healthy PAT CAGR of 35%+ over
FY18-20E. We are factoring in improvement in consolidated RoE (post dilution) to ~20%
and RoA at ~2% by FY20E. EDEL is currently trading at ~3.3x P/Adj book on FY20E, which
is quite attractive considering its robust growth profile, healthy profitability and improving
return ratios. We are valuing the company on SOTP basis, assigning separate value for
each sizeable business. Accordingly, we have arrived at a TP of Rs361, corresponding to
3.6x P/Adj book on FY20E.
Magma Fincorp: The professional management brought in by Magma Fincorp (MGMA)
has focused on improving asset quality and bring in underwriting discipline. Structural
changes implemented in the recent past have started paying off in the form of declining
asset quality pressures and management’s ability to kick-start growth again. Further
improvement in asset quality, return of growth and an overall superior loan portfolio at fairly
cheap valuation make MGMA attractive. ROA is expected to touch 2% going forward. The
stock trades at ~1.5x FY20E Adj. BV and ~12x FY20E EPS for average ROEs of 11%/12%
over FY19E/20E. We recommend BUY with a TP of Rs225.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Relative Valuations
Exhibit 27: FY18 P/B to FY19 ROE Exhibit 28: FY19 P/B to FY20 ROE
8.5 7.5
7.5 y = 0.3187x - 1.6838 6.5 y = 0.2798x - 1.6268
R² = 0.32 R² = 0.2344 BAF
6.5 BAF 5.5
FY18 P/B
5.5
4.5
FY19 P/B
4.5 EDEL EDEL
HDFC
HDFC 3.5 CIFC
3.5 MMFS CIFC MMFS
2.5 SHTF
2.5 MGMA LTFH
LTFH SCUF SHTF
1.5 MGMA 1.5 SCUF
LICHF LICHF
0.5 0.5
11.0 13.0 15.0 17.0 19.0 21.0 23.0 11.0 13.0 15.0 17.0 19.0 21.0 23.0
FY19 RoE FY20 RoE
Source: Bloomberg, Company, Emkay Research Source: Bloomberg, Company, Emkay Research
Exhibit 29: FY18 P/B to FY19 ROA Exhibit 30: FY19 P/B to FY20 ROA
8.5 7.5
y = 1.5311x - 0.0502 y = 1.1856x + 0.3587
7.5 R² = 0.3962 6.5 R² = 0.285
6.5 BAF 5.5 BAF
5.5
FY18 P/B
FY19 P/B
4.5
4.5 EDEL EDEL
3.5 HDFC
HDFC CIFC
3.5 MMFS CIFC
2.5 MGMA SHTF
2.5 LTFH LTFH
SHTF SCUF
1.5 SCUF 1.5 MMFS
LICHF MGMA LICHF
0.5 0.5
1.0 1.5 2.0 2.5 3.0 3.5 4.0 1.0 1.5 2.0 2.5 3.0 3.5 4.0
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
BUY (■) 5.5 %
Bajaj Finance’s (BAF) focus on creating an even more granular portfolio as Change in Estimates
well as broadening its geographic presence has resulted in industry-beating EPS Chg FY19E/FY20E (%) -/-
growth on a consistent basis. At the same time, superior risk management Target Price change (%) NA
processes have ensured excellent credit quality even in challenging business Target Period (Months) 12
environments. We believe that the recent foray into Housing Finance further Previous Reco BUY
strengthens its current dominance as a retail lender, and along with Rural Emkay vs Consensus
Consumer Lending, opens up new growth avenues. EPS Estimates
Diverse product portfolio ensures consistent high growth: Bajaj Finance’s (BAF) well FY19E FY20E
diversified product portfolio (~36 product lines under 4 business verticals) and low product- Emkay 61.2 82.0
specific penetration ensure top quartile growth. BAF’s geographical expansion from urban- Consensus 61.3 80.9
centric to Rural Consumer Lending as well as foray into Housing Finance will open up new Mean Consensus TP (12M) Rs 2,186
growth avenues. FY13-18 AUM CAGR is 37%, while the share of Rural and Consumer Stock Details
Lending increased to 54% in FY18 from 41% in FY13. Bloomberg Code BAF IN
Impressive retail franchise - the proverbial moat: Robust new-to-Bajaj customer Face Value (Rs) 2
additions (6.1mn in FY18, up 50% yoy) despite a large existing customer base (26.2mn at Shares outstanding (mn) 578
end-Mar’18) is clear evidence of a well-established retail franchise. Additionally, BAF 52 Week H/L 2,197 / 1,314
manages to cross-sell to 15.4mn customers, i.e. 3 out of every 5 Bajaj customers. A large M Cap (Rs bn/USD bn) 1,254 / 18.69
EMI card franchise of 12.9mn cards-in-force (as at end-Mar’18) enables BAF to leverage Daily Avg Volume (nos.) 1,230,982
technology to better serve its large customer base. Daily Avg Turnover (US$ mn) 35.5
Sound underwriting practices, limited concentration prevent asset quality gaffes: A Shareholding Pattern Mar '18
granular loan portfolio that limits concentration risks, coupled with excellent credit Promoters 55.1%
underwriting practices keep asset quality under control. (GNPA – 1.48%, PCR – 74.3% as FIIs 19.5%
at Mar’18). This is amply demonstrated in its collection efficiencies and stable asset quality DIIs 9.0%
maintained even during difficult times.
Public and Others 16.4%
Valuations and view: Although investments in geographical expansion and future growth
Price Performance
are expected to keep opex elevated, BAF has consistently clocked superior growth (FY11-
(%) 1M 3M 6M 12M
18: 41%/40% AUM/PAT CAGR) vis-à-vis peers without compromising on asset quality.
Absolute 14 34 29 62
We believe that its foray into Housing Finance and ongoing expansion into Rural
Rel. to Nifty 14 26 22 45
geographies will further reinforce its growth impulses. The stock trades at 5.4x FY20E Adj.
BV and 26x FY20E EPS, for a return profile of average 3.5%+ ROAs / 20%+ ROEs. We Relative price chart
2275 Rs % 50
maintain BUY with a TP of Rs2,375.
2080 38
1885 26
1690 14
1495 2
1300 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 44,065 61,999 87,442 115,255 150,406
Jignesh Shial
Net profit 12,785 18,366 26,467 35,172 47,191
jignesh.shial@emkayglobal.com
EPS (Rs) 23.9 33.7 46.6 61.2 82.0
+91-22-66242468
ABV (Rs) 136.4 170.6 284.5 333.0 403.2
Kushan Parikh, CFA
RoA (%) 3.2 3.3 3.6 3.6 3.6
kushan.parikh@emkayglobal.com
RoE (%) 20.9 21.6 20.3 19.5 21.7
+91-022-66242431
PE (x) 90.8 64.4 46.6 35.5 26.4
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 1,071 1,094 1,150 1,150 1,150
Reserves 73,195 94,909 164,033 195,051 236,704
Net worth 74,266 96,003 165,183 196,201 237,854
Deposits 0 0 0 0 0
Borrowings 370,247 492,495 615,670 844,546 1,171,934
Total liabilities 469,730 637,246 836,290 1,104,120 1,482,093
Cash and bank 13,292 3,565 2,287 (13,255) (27,748)
Investments 10,341 40,747 36,605 42,227 58,597
Loans 438,309 582,394 783,478 1,059,217 1,432,899
Others 4,919 6,928 9,274 10,356 11,654
Total assets 469,730 637,246 836,290 1,104,120 1,482,093
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
18-May-17 1,315 1,450 12m Accumulate Umang Shah
30-Jan-17 1,055 1,360 12m Buy Umang Shah
22-Dec-16 765 1,020 12m Buy Umang Shah Source: Bloomberg, Company, Emkay Research
27-Oct-16 1,105 1,100 12m Hold Umang Shah
6-Sep-16 1,127 1,100 12m Hold Umang Shah
27-Jul-16 979 1,100 12m Hold Umang Shah
25-May-16 734 792 12m Hold Umang Shah
4-Feb-16 634 792 12m Accumulate Umang Shah
21-Oct-15 536 603 12m Accumulate Umang Shah
15-Sep-15 525 602 12m Accumulate Umang Shah
22-Jul-15 513 602 12m Accumulate Umang Shah
14-Jul-15 508 602 12m Accumulate Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12 2018
Emkay
Your success is our success
©
Rating Upside
ACCUMULATE (■) 12.0 %
Cholamandalam Finance (CIFC) has de-risked its product portfolio, which has Change in Estimates
insulated it from the CV down cycle. Among the CV financiers, it has the most EPS Chg FY19E/FY20E (%) -/-
diversified lending portfolio compared to most peers. The company has Target Price change (%) NA
reported robust sales growth, along with stable asset quality. Elevated Target Period (Months) 12
leverage has resulted in superior RoEs, resulting in the stock trading at a Previous Reco ACCUMULATE
premium to peers. However, we also believe that consistently higher earnings Emkay vs Consensus
growth and better ROEs do justify premium valuations. We maintain EPS Estimates
ACCUMULATE with a TP of Rs1,762, valuing it at 3.6x P/Adj. Book on FY20E. FY19E FY20E
Recovery in CV cycle and low market share to help CIFC outpace peers: CIFC de- Emkay 81.4 99.8
risked its business model by diversifying into Home Equity (LAP) business, which helped Consensus 80.0 99.3
it to navigate the CV downturn during FY13-16. We believe that the recovery in the CV Mean Consensus TP (12M) Rs 1,826
cycle and the low market share will throw up immense growth opportunities for CIFC Stock Details
despite rising competition. As at Mar’18, CIFC enjoys ~6% market share in the overall Auto Bloomberg Code CIFC IN
Financing space. Face Value (Rs) 10
Home Equity business to return to normalcy in FY19: In FY17, CIFC’s HE portfolio Shares outstanding (mn) 156
witnessed pressure, both on asset quality as well as growth front due to demonetization. 52 Week H/L 1,761 / 1,016
Gross NPLs rose to 5.5% as at Mar’17 under 90-dpd NPL recognition and credit costs for M Cap (Rs bn/USD bn) 247 / 3.68
FY17 averaged ~85bps. Going forward, we expect this trend to normalize, as the Daily Avg Volume (nos.) 283,561
management is looking at resolution under SARFAESI. Overall GNPLs in HE declined in Daily Avg Turnover (US$ mn) 6.6
Q4FY18 and credit cost also averaged lower at ~60bps for FY18. Moreover, with
Shareholding Pattern Mar '18
expansion in its distribution reach, growth too is likely to pick up pace in FY19.
Promoters 53.1%
Conservative asset quality while maintaining profitability: Over the past two years, FIIs 20.3%
CIFC has fortified its recovery efforts, making it among the few large AFCs to have adopted
DIIs 16.5%
the 90-dpd NPL recognition a year ahead of implementation deadline. As at end-Mar’18,
Public and Others 10.2%
its GNPLs stood at 2.9% on 90-dpd NPL recognition basis. Notably, despite following a
conservative approach, CIFC has been able to maintain / improve its profitability. Price Performance
(%) 1M 3M 6M 12M
Valuation and view: CIFC trades at 3.6x FY20E Adjusted Book for average ROEs of
Absolute (5) 12 23 51
~22% over FY18-20E. While CIFC trades at a premium to some of its larger peers, one
Rel. to Nifty (6) 5 16 36
needs to view its valuation premium in the context of the superior earnings growth, better
ROEs and stellar execution track record. We maintain ACCUMULATE with a TP of Relative price chart
1750 Rs % 50
Rs1,762, corresponding to ~4.0x P/Adj. Book on FY20E.
1610 38
1470 26
1330 14
1190 2
1050 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 21,429 24,295 31,179 38,720 47,176
Jignesh Shial
Net profit 5,685 7,187 9,241 12,743 15,610
jignesh.shial@emkayglobal.com
EPS (Rs) 37.6 46.0 62.3 81.4 99.8
+91-22-66242468
ABV (Rs) 214.4 229.7 281.7 347.0 433.9
Kushan Parikh, CFA
RoA (%) 2.2 2.5 2.8 2.8 2.8
kushan.parikh@emkayglobal.com
RoE (%) 18.0 18.0 20.6 22.3 22.5
+91-022-66242431
PE (x) 41.9 34.3 25.4 19.4 15.8
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 1,562 1,563 1,564 1,564 1,564
Reserves 35,012 41,565 49,938 61,035 74,632
Net worth 36,574 43,129 51,502 62,599 76,196
Deposits 0 0 0 0 0
Borrowings 225,762 242,068 319,023 409,811 515,279
Total liabilities 278,883 307,211 395,046 501,802 625,001
Cash and bank 4,905 4,870 3,925 7,097 9,117
Investments 666 2,385 3,190 2,049 2,576
Loans 260,146 285,836 374,132 477,817 597,325
Others 12,053 12,720 12,191 13,071 14,038
Total assets 278,883 307,211 395,046 501,802 625,001
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
2-May-17 1,092 1,350 12m Accumulate Umang Shah
27-Jan-17 1,048 1,150 12m Accumulate Umang Shah
29-Dec-16 988 1,135 12m Accumulate Umang Shah Source: Bloomberg, Company, Emkay Research
28-Oct-16 1,185 1,370 12m Buy Umang Shah
6-Sep-16 1,109 1,370 12m Buy Umang Shah
1-Aug-16 1,152 1,370 12m Buy Umang Shah
2-May-16 851 1,000 12m Buy Umang Shah
27-Oct-15 602 790 12m Buy Umang Shah
15-Sep-15 618 825 12m Accumulate Umang Shah
14-Jul-15 708 825 12m Accumulate Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Rating Upside
BUY (■) 13.9 %
We maintain BUY on Edelweiss Financial Services (EDEL), as we believe that Change in Estimates
the company would continue to pursue aggressive growth in superior RoE EPS Chg FY19E/FY20E (%) -/-
businesses, which in turn will result in healthy PAT CAGR of 35%+ over FY18- Target Price change (%) NA
20E. We are factoring in improvement in consolidated RoE (post dilution) to Target Period (Months) 12
~20% and RoA at ~2% by FY20E. Previous Reco BUY
Funds Business – Diversification on the cards; Retail to take driver’s seat: Although Emkay vs Consensus
the company has successfully ventured into Corporate Lending to reduce sector EPS Estimates
concentration & earnings volatility and to increase portfolio of better-rated assets, the FY19E FY20E
company plans to increase the share of the Retail portfolio. We are assuming robust growth Emkay 13.6 16.8
in Retail assets against consolidation in Wholesale, resulting in the share of retail rising to Consensus 13.6 17.4
~45% in FY20E. Mean Consensus TP (12M) Rs 358
EDEL ARC – Best placed to capitalise on opportunities: Capital infusion for PSBs, Stock Details
along with upcoming NCLT admissions has finally increased the probability of stressed Bloomberg Code EDEL IN
asset resolutions for Indian banks. This in turn is the most opportunistic time for well Face Value (Rs) 1
capitalized ARCs like EDEL. Shares outstanding (mn) 917
Franchise business continues to witness robust traction – Overall contribution to 52 Week H/L 342 / 170
profitability on the rise: Asset management and capital market businesses had a strong M Cap (Rs bn/USD bn) 304 / 4.53
quarter given the macro tailwinds in these businesses. Overall Assets under Advice (wealth Daily Avg Volume (nos.) 2,544,449
management + MF + alternative assets) stood at Rs1.2trn, up 52% yoy. The PAT Daily Avg Turnover (US$ mn) 10.8
contribution from this businesses has increased to ~35% in FY18 which further reiterates
Shareholding Pattern Mar '18
our positive stance in franchise business.
Promoters 33.6%
Life insurance business witnessing steady growth – General insurance business on FIIs 27.9%
the initial stages: In the life insurance business, the gross premium income grew 52%
DIIs 4.4%
yoy to Rs3.1bn. However, the business continues to remain in the investment mode though
Public and Others 34.2%
the quantum of losses been declining for FY18 stood at Rs1.1bn vs. Rs1.36bn for FY17.
The management also remains confident of developing its general insurance business Price Performance
without any partnership for now. (%) 1M 3M 6M 12M
Healthy margins, improving C/I ratio to accelerate profitability: With the rising share Absolute 14 31 18 68
of better yielding Retail Lending book and a consistent decline in cost of funds (due to its Rel. to Nifty 14 23 11 51
borrowing profile), we expect consolidated margins to remain healthy. This coupled with Relative price chart
the improvement in Cost-to-Income ratio (due to increasing operational efficiencies) would 350 Rs % 60
allow the company to witness PAT CAGR of ~35%+ over FY18-20E. 310 46
Attractively priced – Maintain BUY: EDEL is currently trading at ~3.3x P/Adj book on 270 32
FY20E, which is quite attractive considering its robust growth profile, healthy profitability 230 18
and improving return ratios. We are valuing the company on SOTP basis, assigning 190 4
separate value for each sizeable business. Accordingly, we have arrived at a TP of Rs361,
150 -10
corresponding to 3.6x P/Adj book on FY20E. Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Consolidated)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 26,480 38,091 51,158 66,135 82,192
Jignesh Shial
Net profit 4,144 6,093 8,901 12,356 15,225
jignesh.shial@emkayglobal.com
EPS (Rs) 5.0 7.0 9.8 13.6 16.8
+91-22-66242468
ABV (Rs) 43.2 48.8 72.5 83.9 98.1
Kushan Parikh, CFA
RoA (%) 1.5 1.6 1.8 1.8 0.0
kushan.parikh@emkayglobal.com
RoE (%) 12.1 15.2 16.2 17.2 18.1
+91-022-66242431
PE (x) 66.7 47.1 33.8 24.4 19.8
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 814 833 916 916 916
Reserves 42,903 52,047 76,709 87,045 100,046
Net worth 43,717 52,879 77,624 87,960 100,961
Deposits 0 0 0 0 0
Borrowings 277,731 333,790 464,097 571,639 675,413
Total liabilities 369,846 448,234 635,135 776,332 921,866
Cash and bank 19,340 26,182 39,259 37,966 23,962
Investments 26,964 68,777 90,754 108,905 130,686
Loans 167,803 200,995 281,422 351,778 422,133
Others 148,794 144,902 216,162 269,768 336,774
Total assets 369,846 448,234 635,135 776,332 921,866
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
40
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
Source: Bloomberg, Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
HOLD (■) 18.0 %
Given the asset quality challenges and slowdown in demand for corporate Change in Estimates
credit, Housing Finance has been the obvious choice for banks to fall back on EPS Chg FY19E/FY20E (%) -/-
during the easing interest rate scenario. However, during a tightening Target Price change (%) NA
monetary cycle, pure HFCs are the most vulnerable compared to other NBFCs. Target Period (Months) 12
HDFC is already facing pressure in the form of higher pre-payments and Previous Reco HOLD
margin compressions. We remain conservative towards HFCs considering the Emkay vs Consensus
sluggish housing demand and rising exposure to Developer Finance. We EPS Estimates
maintain HOLD with a TP of Rs2,171, corresponding to ~6.0x P/Adj book on
FY19E FY20E
FY20E.
Emkay 59.4 66.9
Developer Loans seeing pick-up in demand: While demand in the Individual Home Consensus 57.9 66.7
Loan segment remains tepid, growth in the Corporate Loan and Other Loan segments Mean Consensus TP (12M) Rs 2,149
has seen some traction over the past few quarters. Demand in this segment is mainly Stock Details
driven by Developer Loans and Rental Discounting, while Corporate Loans continue to Bloomberg Code HDFC IN
witness some pressure. We expect demand in this segment to improve gradually, which Face Value (Rs) 2
is also positive for HDFC’s spreads. However, in FY18, the share of retail loans in
Shares outstanding (mn) 1,680
incremental growth stood at 75% vs. 71% in FY17.
52 Week H/L 1,986 / 1,591
Affordable Housing – the next big opportunity?: Government has sharpened its focus M Cap (Rs bn/USD bn) 3,136 / 46.75
on Affordable Housing and has announced a slew of measures (CLSS scheme, tax Daily Avg Volume (nos.) 2,787,708
incentives for borrowers and fiscal sops for developers engaged in Affordable Housing) Daily Avg Turnover (US$ mn) 76.5
to revive the housing sector. Regulatory sops have been announced to boost demand
Shareholding Pattern Mar '18
and supply (for developers) for Affordable Housing. We believe these measures could
result in higher demand in the medium term. But, in the near term, demand in the home Promoters -%
Valuation and view: HDFC's growth momentum has moderated given the limited Rel. to Nifty (3) - 6 5
opportunities in the Corporate Loan segment and slowing pace of retail loans. While NIMs Relative price chart
1975 Rs % 10
and asset quality are likely to remain stable, revival in growth will be crucial. Further
announcements to unlock value in subsidiaries could drive up valuations. We maintain 1900 6
1750 -2
1675 -6
1600 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 115,821 122,634 129,949 159,478 178,796
Jignesh Shial
Net profit 70,931 74,426 121,637 101,639 114,574
jignesh.shial@emkayglobal.com
EPS (Rs) 44.9 46.8 72.6 59.4 66.9
+91-22-66242468
ABV (Rs) 214.4 248.0 371.9 433.5 473.2
Kushan Parikh, CFA
RoA (%) 2.7 2.4 3.1 2.4 2.3
kushan.parikh@emkayglobal.com
RoE (%) 21.8 20.2 22.1 15.2 15.1
+91-022-66242431
PE (x) 41.6 39.8 25.7 31.5 27.9
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 3,160 3,177 3,352 3,425 3,425
Reserves 337,540 392,766 610,170 720,985 787,475
Net worth 340,700 395,943 613,522 724,409 790,900
Deposits 2,377,629 2,797,322 3,199,121 3,772,012 4,424,200
Borrowings 0 0 0 0 0
Total liabilities 2,888,766 3,363,579 4,016,744 4,720,933 5,462,062
Cash and bank 54,925 64,617 13,714 99,831 38,641
Investments 153,454 204,101 305,325 320,591 336,621
Loans 2,592,244 2,964,718 3,594,420 4,191,124 4,971,011
Others 81,498 123,719 96,840 102,877 109,215
Total assets 2,888,766 3,363,579 4,016,744 4,720,933 5,462,062
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
4-May-17 1,564 1,528 12m Hold Umang Shah
31-Jan-17 1,366 1,467 12m Hold Umang Shah
2-May-16 1,092 1,295 12m Accumulate Umang Shah Source: Bloomberg, Company, Emkay Research
28-Jan-16 1,148 1,300 12m Hold Sohail Halai
27-Oct-15 1,275 1,330 12m Hold Sohail Halai
28-Jul-15 1,304 1,348 12m Hold Sohail Halai
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
HOLD (■) 14.7 %
Adversely affected due to rising yields and increasing competition: Given the asset Previous Reco HOLD
quality challenges and slowdown in demand for corporate credit, Housing Finance has Emkay vs Consensus
been the obvious choice for banks to fall back on as a safe haven during an easing interest EPS Estimates
rate scenario. However, during a tightening monetary cycle, pure HFCs like LICHF are the FY19E FY20E
most adversely affected compared to other NBFCs. The company is already facing Emkay 47.1 54.7
pressure in the form of higher pre-payments and margin compressions. Although being Consensus 45.7 53.2
primarily wholesale funded, LICHF has derived the maximum advantage from the recent Mean Consensus TP (12M) Rs 621
fall in yields, going forward rising yields would be a major headwind along with increasing Stock Details
competition, especially from large banks. Bloomberg Code LICHF IN
Growth likely to remain subdued: In FY18, LICHF’s loan book grew by 15.1%, as core Face Value (Rs) 2
Individual Home Loans grew at a slower pace of ~11%. The moderation in growth can be Shares outstanding (mn) 505
attributed to sluggish demand environment and stiff competition. The repayment/pre- 52 Week H/L 794 / 463
payment rate for LICHF remains elevated. Given the stiff competition in the Housing M Cap (Rs bn/USD bn) 249 / 3.71
Finance space, growth is unlikely to spurt meaningfully in the near term. Daily Avg Volume (nos.) 1,846,921
Daily Avg Turnover (US$ mn) 14.3
NIMs under pressure despite better growth in high yielding loans and lower costs:
In FY18, LICHF recorded 32bps contraction in NIM to 2.38%, despite: 1) Better growth in Shareholding Pattern Mar '18
relatively high-yielding non-individual loans - indicates the inability of the management to Promoters 40.3%
price risks appropriately and 2) 19bps fall in calculated cost of funds. Rising competition FIIs 32.9%
along with LICHF’s inability to command better pricing power resulted in overall spreads
DIIs 8.3%
getting compressed. Going forward, we expect NIMs to remain stable.
Public and Others 18.5%
Asset quality to remain stable: LICHF’s asset quality remains largely stable, mainly
Price Performance
driven by the strong asset quality performance in Individual Home Loans. Moreover, the
(%) 1M 3M 6M 12M
company has made all necessary provisions towards NPLs in the Developer Loans
Absolute (4) - (12) (33)
segment. Hence, we do not foresee any major pressure on asset quality/credit costs. The
management has remained confident of recovering bad loans in the Individual Home Loan Rel. to Nifty (5) (5) (17) (40)
segment. However, recoveries from corporate NPLs may take a few quarters. Relative price chart
800 Rs % 0
Valuation and view: Heightened competition in the Individual Home Loan segment could 730 -10
put pressure on LICHF’s growth/margins. Considering this, pure Housing Finance
660 -20
companies like LICHF have faced pressure in the form of higher pre-payments and margin
compressions. Although being primarily wholesale funded, LICHF has gained the 590 -30
maximum advantage from the recent fall in yields, we continue to remain conservative due 520 -40
to the company’s slowing growth and increasing non-core housing book. We maintain our 450 -50
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
HOLD with a TP of Rs572, corresponding to ~1.8x P/Adj. FY20E book. LIC Housing Finance (LHS) Rel to Nifty (RHS)
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 31,787 38,488 39,482 47,585 55,629
Jignesh Shial
Net profit 16,608 19,310 19,896 23,761 27,620
jignesh.shial@emkayglobal.com
EPS (Rs) 32.9 38.2 39.4 47.1 54.7 +91-22-66242468
ABV (Rs) 177.2 216.5 241.6 279.0 324.0
Kushan Parikh, CFA
RoA (%) 1.4 1.4 1.2 1.3 1.3 kushan.parikh@emkayglobal.com
RoE (%) 19.6 19.1 16.7 17.4 17.5 +91-022-66242431
PE (x) 15.0 12.9 12.5 10.5 9.0
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 1,010 1,010 1,010 1,010 1,010
Reserves 90,450 109,760 125,897 145,419 168,111
Net worth 91,460 110,770 126,907 146,429 169,121
Deposits 1,084,312 1,238,371 1,375,906 1,626,241 1,900,444
Borrowings 0 0 0 0 0
Total liabilities 1,296,869 1,499,833 1,718,520 2,028,302 2,372,828
Cash and bank 39,268 44,633 29,535 76,847 108,861
Investments 2,768 5,270 9,868 10,457 11,089
Loans 1,251,732 1,445,340 1,663,230 1,924,545 2,235,817
Others 0 0 0 0 0
Total assets 1,296,869 1,499,833 1,718,520 2,028,302 2,372,828
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
17-Jan-17 532 570 12m Hold Umang Shah
21-Oct-16 600 625 12m Hold Umang Shah
19-Jul-16 508 500 12m Hold Umang Shah Source: Bloomberg, Company, Emkay Research
20-Apr-16 467 500 12m Hold Umang Shah
19-Jan-16 470 515 12m Hold Sohail Halai
16-Oct-15 495 515 12m Hold Sohail Halai
21-Jul-15 465 515 12m Hold Sohail Halai
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
BUY (■) 41.8 %
L&T Finance Holdings (LTFH) has successfully transformed its lending Change in Estimates
business to focus on ROEs and sustainable growth. Consolidated ROE has EPS Chg FY19E/FY20E (%) -/-
improved from 10% in FY16 to ~15% in FY18. Being a diversified financial Target Price change (%) NA
services player, LTFH has multiple levers of growth (~7 product lines under 3 Target Period (Months) 12
business verticals in the lending business). Moreover, a robust and Previous Reco BUY
sustainable fee income franchise helps it to maintain profitability. We expect Emkay vs Consensus
this will enable LTFH to clock consolidated PAT CAGR of 40% over FY18-20E. EPS Estimates
Lending business transformed; focus on increasing share of retail: As part of its FY19E FY20E
business transformation, LTFH chose to reduce its dependence on the legacy Wholesale Emkay 10.7 14.4
Lending business and focus on increasing the share of Retail. This not only helped the Consensus 10.0 13.3
company to improve its overall profitability but also mitigated risks by making the portfolio Mean Consensus TP (12M) Rs 224
more granular in nature. As a result, the share of Retail has increased from 32% in FY16 Stock Details
to 42% in FY18. Moreover, the share of Retail segment’s profit in the overall lending Bloomberg Code LTFH IN
business profit too has risen to 62.5% in FY18 vs. 41% in FY16. Face Value (Rs) 10
Management confident of maintaining high fee income growth: A strong sell-down Shares outstanding (mn) 1,996
desk and domain expertise in the Wholesale Lending business gives LTFH confidence to 52 Week H/L 214 / 130
sustain high fee income. Fees as % of AUM stood at ~20-50bps across Wholesale and M Cap (Rs bn/USD bn) 334 / 4.98
Retail businesses, enabling the management to sustain better margins. Daily Avg Volume (nos.) 4,180,067
Daily Avg Turnover (US$ mn) 10.5
ROE drag from wholesale business will gradually subside: The Wholesale book
consists largely of Infrastructure loans. The provision required against this book is Rs25- Shareholding Pattern Mar '18
27bn, of which Rs14bn has already been provided for and the balance would be provided Promoters 64.0%
for in FY19. LTFH expects the Wholesale business ROE to gradually rise to 15% (current FIIs 9.6%
ROE is 8-9%). Renewables, operational Road Projects and Transmission business are the
DIIs 5.4%
new focus segments within the Wholesale business.
Public and Others 21.0%
Valuations and view: We believe that LTFH’s successful turnaround of the lending
Price Performance
business and focus on realization of the book will aid in sustainably improving its
(%) 1M 3M 6M 12M
profitability and return ratios. Scaling of the non-lending business will also aid in improving
Absolute (5) 6 (3) 27
profitability. However, the drag from the Wholesale business is likely to endure in the near
Rel. to Nifty (6) - (8) 14
term. Given the favorable risk-reward on balance, we maintain BUY with a TP of Rs238.
Relative price chart
225 Rs % 60
200 48
175 36
150 24
125 12
100 0
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Consolidated)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 33,466 39,453 51,738 64,324 78,893
Jignesh Shial
Net profit 8,567 10,422 14,595 21,905 28,343
jignesh.shial@emkayglobal.com
EPS (Rs) 3.8 5.1 6.9 10.7 14.4
+91-22-66242468
ABV (Rs) 32.2 36.6 56.4 65.2 78.5
Kushan Parikh, CFA
RoA (%) 1.1 1.3 1.7 2.1 2.3
kushan.parikh@emkayglobal.com
RoE (%) 9.7 12.3 13.3 15.7 18.2
+91-022-66242431
PE (x) 44.2 32.6 24.4 15.6 11.6
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 17,534 17,557 19,957 19,957 19,957
Reserves 53,237 60,201 105,542 123,677 148,417
Net worth 70,771 77,759 125,499 143,634 168,374
Deposits 0 0 0 0 0
Borrowings 516,157 598,111 715,771 898,012 1,124,230
Total liabilities 637,993 725,112 892,306 1,095,781 1,347,205
Cash and bank 4,015 5,944 10,633 (11,196) (24,850)
Investments 35,633 60,115 48,433 53,881 61,833
Loans 560,654 616,485 782,992 997,791 1,249,144
Others 30,730 36,379 44,936 49,728 55,222
Total assets 637,993 725,112 892,306 1,095,781 1,347,205
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
82
40
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
Source: Bloomberg, Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
BUY (■) 34.8 %
Change in Estimates
The professional management brought in by Magma Fincorp (MGMA) has
EPS Chg FY19E/FY20E (%) -/-
focused on improving asset quality and bring in underwriting discipline.
Target Price change (%) NA
Structural changes implemented in the recent past have started paying off in
Target Period (Months) 12
the form of declining asset quality pressures and management’s ability to
kick-start growth again. Further improvement in asset quality, return of growth Previous Reco BUY
and an overall superior loan portfolio at fairly cheap valuation makes MGMA Emkay vs Consensus
Asset quality improvement likely to continue: Structural changes effected by the new FIIs 40.7%
management have helped the company to tackle asset quality troubles, as absolute DIIs 22.1%
GNPLs have declined from Rs14.6bn (10.4%) in FY16 to Rs8.5bn (7%) in FY18. The Public and Others 12.8%
company has shifted to 90-dpd NPL recognition as on Mar’18 and expects credit costs to
Price Performance
trend downwards from FY19 onwards.
(%) 1M 3M 6M 12M
Valuations and view: Further improvement in asset quality, return of growth and an Absolute (3) 14 3 36
overall superior loan portfolio at fairly cheap valuation make MGMA attractive. ROA is Rel. to Nifty (3) 8 (2) 22
expected to touch 2% going forward. The stock trades at ~1.5x FY20E Adj. BV and ~12x Relative price chart
FY20E EPS for average ROEs of 11%/12% over FY19E/20E. We recommend BUY with a 200 Rs % 30
TP of Rs225. 180 22
160 14
140 6
120 -2
100 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Consolidated)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 13,203 12,752 13,925 14,606 16,761
Jignesh Shial
Net profit 2,114 205 2,304 2,930 3,903
jignesh.shial@emkayglobal.com
EPS (Rs) 9.1 0.9 9.7 10.9 14.5
+91-22-66242468
ABV (Rs) 57.8 65.3 79.1 100.1 115.6
Kushan Parikh, CFA
RoA (%) 1.4 0.1 1.7 2.0 2.2
kushan.parikh@emkayglobal.com
RoE (%) 11.1 0.9 10.3 10.9 12.0
+91-022-66242431
PE (x) 18.9 199.5 17.7 15.8 11.9
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 474 474 474 539 539
Reserves 21,039 21,247 22,720 30,197 33,776
Net worth 21,513 21,721 23,194 30,736 34,315
Deposits 0 0 0 0 0
Borrowings 118,455 100,753 86,985 101,919 123,134
Total liabilities 155,245 135,952 137,013 163,243 190,841
Cash and bank 4,084 3,533 4,179 8,521 5,787
Investments 3,997 5,465 6,485 8,154 9,851
Loans 141,341 120,624 121,692 141,595 169,888
Others 3,651 4,089 2,653 2,829 3,020
Total assets 155,245 135,952 137,013 163,243 190,841
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
12-May-17 133 150 12m Buy Umang Shah
5-Apr-17 122 150 12m Buy Umang Shah
10-Feb-17 98 115 12m Accumulate Umang Shah Source: Bloomberg, Company, Emkay Research
4-Nov-16 101 120 12m Buy Umang Shah
6-Sep-16 100 125 12m Buy Umang Shah
16-Aug-16 102 125 12m Buy Umang Shah
28-Jun-16 105 130 12m Buy Umang Shah
13-May-16 89 130 12m Buy Umang Shah
28-Mar-16 76 130 12m Buy Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
ACCUMULATE (■) 5.6 %
Over the past few years, Mahindra Finance (MMFS) had been reeling under the Change in Estimates
pressure of deteriorating asset quality and rising credit costs. However, the EPS Chg FY19E/FY20E (%) -/-
scenario is improving gradually. While the government’s focus on Agriculture Target Price change (%) NA
and Rural Infra along with forecast of normal monsoon will boost tractor Target Period (Months) 12
demand, pressure on credit costs will ease, as the shift to 90-day NPA Previous Reco ACCUMULATE
recognition is already completed. With demand for tractors sustaining, we Emkay vs Consensus
expect positive earnings surprise in the form of previous year’s recoveries. EPS Estimates
We recommend ACCUMULATE with a TP of Rs515, corresponding to ~3.0x
FY19E FY20E
P/Adj FY20E book.
Emkay 21.2 28.7
Rise in tractor demand to drive growth: The government’s higher allocation towards Consensus 22.7 29.1
Rural and Agri sectors in the Union Budget should help the rural economy to gather pace. Mean Consensus TP (12M) Rs 554
The company remains a key beneficiary of an uptick in tractor demand, and with Stock Details
sustainability of the demand cycle in tractors, we may see positive earnings surprises in Bloomberg Code MMFS IN
the form of previous year’s recoveries. Face Value (Rs) 2
Asset quality pressures likely to ease: Over the past few years, MMFS has witnessed Shares outstanding (mn) 618
a sharp uptick in its NPLs on account of back-to-back failed monsoons, lower government 52 Week H/L 538 / 322
spending and tighter regulatory norms. While monsoon and government spending started M Cap (Rs bn/USD bn) 302 / 4.45
to turn favourable in FY17, demonetization adversely affected the rural economy, thereby Daily Avg Volume (nos.) 1,827,107
worsening MMFS’ asset quality. Consequently, in FY17, post the withdrawal of the RBI Daily Avg Turnover (US$ mn) 12.9
dispensation, NPLs rose to 9% levels while the NPL recognition norms remained at 120-
Shareholding Pattern Mar '18
dpd (same as in FY16). Even as the company migrated to 90-dpd NPL recognition in FY18,
GNPLs declined to 8.5%. Management has guided for consistent improvement in collection Promoters 51.2%
efficiencies with the rise in rural spending and favorable macro trends. Recovery from the FIIs 29.4%
previous year’s NPAs would be an added kicker for RoA improvement. DIIs 11.6%
Public and Others 7.8%
Valuations and view: While the government’s focus on Agriculture and Rural Infra is likely
to boost demand, completing the shift to 90-day NPA recognition will ease pressure on Price Performance
credit costs. The company remains a key beneficiary of the uptick in tractor demand, and (%) 1M 3M 6M 12M
with sustainability of this demand cycle, we may see positive earnings surprises in the form Absolute (3) 16 8 35
of previous year’s recoveries. We recommend ACCUMULATE with a TP of Rs515, Rel. to Nifty (4) 11 3 21
corresponding to ~3.0x P/Adj. FY20E book. Relative price chart
550 Rs % 40
500 30
450 20
400 10
350 0
300 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 32,658 33,801 42,057 50,371 59,968
Jignesh Shial
Net profit 6,726 4,002 7,406 13,114 17,746
jignesh.shial@emkayglobal.com
EPS (Rs) 11.8 7.0 15.3 21.2 28.7
+91-22-66242468
ABV (Rs) 91.9 94.2 139.2 150.0 172.7
Kushan Parikh, CFA
RoA (%) 1.8 0.9 1.8 2.2 2.5
kushan.parikh@emkayglobal.com
RoE (%) 11.4 6.4 11.3 13.4 16.2
+91-022-66242431
PE (x) 41.2 69.3 31.8 23.0 17.0
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 1,129 1,130 1,229 1,229 1,229
Reserves 59,752 63,642 91,802 101,321 114,753
Net worth 60,881 64,772 93,031 102,550 115,982
Deposits 0 0 0 0 0
Borrowings 294,523 346,704 355,353 437,383 519,202
Total liabilities 395,795 459,852 543,678 652,539 766,514
Cash and bank 5,890 5,781 4,111 16,244 7,893
Investments 14,833 18,895 18,732 21,869 25,960
Loans 366,577 425,234 510,686 604,047 722,023
Others 7,359 8,823 8,952 9,003 9,056
Total assets 395,794 459,852 543,678 652,539 766,514
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
25-Apr-17 340 290 12m Sell Umang Shah
14-Mar-17 280 240 12m Sell Umang Shah
25-Jan-17 286 240 12m Sell Umang Shah Source: Bloomberg, Company, Emkay Research
26-Oct-16 363 363 12m Accumulate Umang Shah
26-Jul-16 314 363 12m Accumulate Umang Shah
25-Apr-16 298 390 12m Buy Umang Shah
22-Jan-16 200 191 12m Sell Umang Shah
23-Oct-15 237 215 12m Sell Umang Shah
15-Sep-15 236 225 12m Sell Umang Shah
27-Jul-15 265 225 12m Sell Umang Shah
14-Jul-15 279 262 12m Reduce Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
HOLD (■) 5.9 %
Shriram City Union Finance (SCUF) has built a niche and diversified business Change in Estimates
model, focusing on the underserved and under-penetrated MSME segment in EPS Chg FY19E/FY20E (%) -/-
the Rural and Semi Urban areas. AUM in Q4FY18 grew by 18.7% yoy (5.3% Target Price change (%) NA
qoq) to Rs274bn in spite of relatively weak disbursements growth of 6.2% yoy, Target Period (Months) 12
mainly due to increasing tenure of existing loans across segments. Given the Previous Reco HOLD
waning of problems related to the Gold Loan business and demonetization Emkay vs Consensus
and its strong capital position, SCUF remains well poised for its next phase of EPS Estimates
growth. ROEs will improve gradually as leverage increases.
FY19E FY20E
Getting back on the growth path: In FY17, the company weathered challenges related Emkay 128.6 162.4
to demonetization and limits imposed on cash disbursements for Gold Loans. We believe Consensus 142.2 176.0
that with both these pain points behind now, the company is back on the growth path with Mean Consensus TP (12M) Rs 2,638
demand in the SME and 2W segments returning to normalcy. The company is gradually Stock Details
expanding in the non-core segments, which is driving growth. With the portfolio realignment Bloomberg Code SCUF IN
largely done and given its strong capital position (20.6% Tier I capital as at Mar’18), we Face Value (Rs) 10
expect SCUF to get back in growth mode.
Shares outstanding (mn) 66
Downside risks to margins limited: Despite rising NPLs as well as heightened 52 Week H/L 2,648 / 1,850
competition, SCUF has been able to protect its NIMs given its strong presence in the high- M Cap (Rs bn/USD bn) 152 / 2.24
yielding segments. Although we may witness some compression in margins on the back Daily Avg Volume (nos.) 26,598
of enhanced leverage (resulting in lower benefits of capital and large part of incremental Daily Avg Turnover (US$ mn) 0.9
growth coming from non-core markets where yields could be lower than home markets),
Shareholding Pattern Mar '18
with interest reversal down post 90-day NPA recognition and increasing traction in 2W, we
expect margins to still remain healthy. Promoters 33.8%
FIIs 25.4%
Credit cost likely to ease with improvement in recoveries: As at end-Mar’18, SCUF
DIIs 6.0%
shifted to 90-dpd NPL recognition. Post this, overall slippage would be in line with industry
Public and Others 34.9%
cycle, with limited probability of major negative surprises. In our view, credit cost may fall
from FY19 on the back of overall improvement in demand and enhanced recoveries. Price Performance
(%) 1M 3M 6M 12M
Valuation and view: SCUF’s niche business model offers high growth potential with strong
Absolute (3) 17 10 (7)
profitability and low competition. The companies target customer segments such as the
SME business segment still remain underserved by the formal banking channels, and Rel. to Nifty (4) 11 5 (17)
hence offer huge growth potential. We maintain HOLD with TP of Rs2,449, corresponding Relative price chart
2550 Rs % 10
to 2.5x P/Adj FY20E book for average ROEs of ~15% over FY19E/20E.
2410 2
2270 -6
2130 -14
1990 -22
1850 -30
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 24,726 29,001 34,339 40,629 47,161
Jignesh Shial
Net profit 5,298 5,561 6,647 8,490 10,720
jignesh.shial@emkayglobal.com
EPS (Rs) 80.3 84.2 100.7 128.6 162.4
+91-22-66242468
ABV (Rs) 652.0 718.4 743.8 858.1 972.2
Kushan Parikh, CFA
RoA (%) 2.7 2.5 2.5 2.7 2.8
kushan.parikh@emkayglobal.com
RoE (%) 12.3 11.7 12.5 14.4 16.0
+91-022-66242431
PE (x) 28.7 27.3 22.8 17.9 14.2
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 659 659 660 660 660
Reserves 44,457 49,625 55,002 61,948 71,124
Net worth 45,116 50,284 55,662 62,608 71,784
Deposits 0 0 0 0 0
Borrowings 144,084 170,420 188,238 228,914 280,448
Total liabilities 208,544 245,365 289,684 343,606 409,970
Cash and bank 6,419 6,371 5,321 2,778 3,910
Investments 7,923 7,145 7,280 11,446 14,022
Loans 191,406 229,614 274,869 327,019 389,511
Others 1,947 1,453 1,425 1,495 1,572
Total assets 208,544 245,365 289,684 343,606 409,970
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
9-Dec-17
9-Jun-18
12-Dec-15
10-Dec-16
13-Jun-15
11-Jun-16
10-Jun-17
3-May-17 2,139 2,100 12m Hold Umang Shah
31-Jan-17 1,894 2,220 12m Hold Umang Shah
28-Oct-16 2,497 2,445 12m Hold Umang Shah Source: Bloomberg, Company, Emkay Research
28-Sep-16 2,181 2,445 12m Hold Umang Shah
24-Jun-16 1,592 1,655 12m Hold Umang Shah
28-Apr-16 1,659 1,655 12m Hold Umang Shah
30-Jan-16 1,415 1,748 12m Accumulate Umang Shah
30-Oct-15 1,840 2,013 12m Accumulate Umang Shah
15-Sep-15 1,700 2,013 12m Accumulate Umang Shah
14-Jul-15 1,680 2,013 12m Accumulate Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Company Update
June 12, 2018
Emkay
Your success is our success
©
Rating Upside
BUY (■) 24.2 %
Change in Estimates
Healthy AUM growth, aided by a favorable CV cycle, improved demand for EPS Chg FY19E/FY20E (%) -/-
Used CVs and reduced credit cost (post 90-day NPA recognition) make SHTF
Target Price change (%) NA
one of the most preferred stocks in our NBFC coverage universe. In spite of
Target Period (Months) 12
the recent run-up, the stock remains at a comfortable discount to most peers
Previous Reco BUY
(Cholamandalam, Sundaram etc), which should narrow gradually. We
Emkay vs Consensus
recommend BUY with a TP of Rs1,818, corresponding to ~2.7x P/Adj FY20E
EPS Estimates
book with superior RoA of 2.6% and RoE of 18.5% for FY20E.
FY19E FY20E
Ideally placed to play upswing in CV cycle: With AUM of ~Rs953bn (as on Mar’18), Emkay 105.4 129.7
SHTF is the largest asset financing NBFC in India. Due to a higher base and weak CV
Consensus 104.9 129.9
demand, SHTF reported ~12% CAGR in AUM during FY12-17 against its previous peak
Mean Consensus TP (12M) Rs 1,764
levels of ~18% CAGR. The company is able to manage its market share, especially in
Stock Details
Used CVs, which anyhow has limited competition not only from banks but also from other
Bloomberg Code SHTF IN
peers. Our recent discussions with the management as well as other industry players
Face Value (Rs) 10
suggest that the current uptick in CV demand is sustainable and well supported by the rise
Shares outstanding (mn) 227
in government spending on infrastructure (especially road sector), and improving rural-
52 Week H/L 1,671 / 898
centric activities. Hence, we expect SHTF to return to its healthy AUM growth level of ~18%
CAGR during FY18-20E. M Cap (Rs bn/USD bn) 331 / 4.94
Daily Avg Volume (nos.) 873,353
Downside risks to margins limited: Despite rising NPLs and growing competition, SHTF Daily Avg Turnover (US$ mn) 19.5
has been able to protect its NIMs given its strong presence in the high-yielding segments
as well as effective utilization of its liability franchise. Going forward, with lower interest Shareholding Pattern Mar '18
reversal (on shift to 90-day NPL recognition), along with increasing traction in Used Promoters 26.1%
Vehicles, we expect margins to still remain healthy for FY18-20E. FIIs 49.5%
DIIs 4.0%
Credit costs likely to ease with improvement in recoveries: As at end-Mar18, SHTF
has shifted to recognize NPLs on 90-dpd basis. From here onwards, overall slippage trend Public and Others 20.4%
would be in line with industry cycle with limited probability of major negative surprises. In Price Performance
our view, credit costs may see a declining trend from FY19 with overall improvement in (%) 1M 3M 6M 12M
demand and rising recoveries.
Absolute (7) 10 8 46
Valuation and view: The stock still remains at a comfortable discount to most peers Rel. to Nifty (7) 4 2 31
(Cholamandalam, Sundaram etc.), which according to us should narrow gradually. We Relative price chart
recommend BUY with a TP of Rs1,818, corresponding to ~2.7x P/Adj FY20E book with 1650 Rs % 60
1350 32
1200 18
1050 4
900 -10
Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18
Source: Bloomberg
Financial Snapshot (Standalone)
This report is solely produced by Emkay Global. The
(Rs mn) FY16 FY17 FY18 FY19E FY20E following person(s) are responsible for the production
of the recommendation:
Net income 50,295 56,432 69,825 82,508 93,561
Jignesh Shial
Net profit 11,782 12,573 15,680 23,921 29,431
jignesh.shial@emkayglobal.com
EPS (Rs) 51.9 55.4 69.1 105.4 129.7
+91-22-66242468
ABV (Rs) 412.3 447.0 488.4 568.1 671.0
Kushan Parikh, CFA
RoA (%) 1.9 1.8 1.9 2.5 2.6
kushan.parikh@emkayglobal.com
RoE (%) 12.2 11.7 13.1 17.6 18.5
+91-022-66242431
PE (x) 28.1 26.4 21.1 13.9 11.3
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer
to the last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Balance Sheet
Y/E Year End (Rs mn) FY16 FY17 FY18 FY19E FY20E
Equity 2,269 2,269 2,269 2,269 2,269
Reserves 99,272 110,753 123,454 144,080 169,943
Net worth 101,541 113,022 125,723 146,350 172,212
Deposits 0 0 0 0 0
Borrowings 497,907 531,101 633,200 737,746 867,485
Total liabilities 679,633 744,103 884,704 1,033,967 1,215,457
Cash and bank 23,639 44,407 36,375 38,857 46,255
Investments 13,562 15,493 14,795 18,444 21,687
Loans 637,701 678,402 827,400 970,349 1,140,994
Others 3,722 4,963 4,934 4,998 5,069
Total assets 679,633 744,103 884,704 1,033,967 1,215,457
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
4-Jun-16
26-Nov-17
7-Dec-15
1-Dec-16
30-May-17
25-May-18
10-Jun-15
13-Jul-17 1,026 - 12m UR Umang Shah
27-Apr-17 1,041 850 12m Reduce Umang Shah
31-Jan-17 955 880 12m Reduce Umang Shah Source: Bloomberg, Company, Emkay Research
26-Oct-16 1,128 849 12m Reduce Umang Shah
6-Sep-16 1,238 849 12m Reduce Umang Shah
28-Jul-16 1,233 849 12m Reduce Umang Shah
2-May-16 1,083 849 12m Reduce Umang Shah
1-Feb-16 810 771 12m Sell Umang Shah
30-Oct-15 943 771 12m Sell Umang Shah
15-Sep-15 855 771 12m Sell Umang Shah
3-Aug-15 918 771 12m Sell Umang Shah
14-Jul-15 907 771 12m Sell Umang Shah
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Sources for all charts and tables are Emkay Research unless otherwise specified.
Disclaimer for U.S. persons only: This research report is a product of Emkay Global Financial Services Limited (Emkay), which is the employer of the
research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States
(U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-
dealer, and is/are not required to satisfy the regulatory licensing requirements of Financial Institutions Regulatory Authority (FINRA) or required to otherwise
comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities
held by a research analyst account. This report is intended for distribution to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S.
Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on
Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the
same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional
Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to
conduct certain business with Major Institutional Investors.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS Bank
Ltd, its respective connected and associated corporations, affiliates and their respective directors, officers, employees and agents (collectively, the “DBS
Group”) have not conducted due diligence on any of the companies, verified any information or sources or taken into account any other factors which we
may consider to be relevant or appropriate in preparing the research. Accordingly, we do not make any representation or warranty as to the accuracy,
completeness or correctness of the research set out in this report. Opinions expressed are subject to change without notice. This research is prepared for
general circulation. Any recommendation contained in this document does not have regard to the specific investment objectives, financial situation and
the particular needs of any specific addressee. This document is for the information of addressees only and is not to be taken in substitution for the
exercise of judgement by addressees, who should obtain separate independent legal or financial advice. The DBS Group accepts no liability whatsoever
for any direct, indirect and/or consequential loss (including any claims for loss of profit) arising from any use of and/or reliance upon this document and/or
further communication given in relation to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any
securities. The DBS Group, along with its affiliates and/or persons associated with any of them may from time to time have interests in the securities
mentioned in this document. The DBS Group, may have positions in, and may effect transactions in securities mentioned herein and may also perform or
seek to perform broking, investment banking and other banking services for these companies. Any valuations, opinions, estimates, forecasts, ratings or
risk assessments herein constitutes a judgment as of the date of this report, and there can be no assurance that future results or events will be consistent
with any such valuations, opinions, estimates, forecasts, ratings or risk assessments. The information in this document is subject to change without notice,
its accuracy is not guaranteed, it may be incomplete or condensed, it may not contain all material information concerning the company (or companies)
referred to in this report and the DBS Group is under no obligation to update the information in this report. This publication has not been reviewed or
authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned schedule or frequency for updating research publication
relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on which the
valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual results.
Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED UPON as
a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that: (a) such valuations, opinions,
estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and (b) there is any assurance that future results or
events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments stated therein. Please contact the primary
analyst for valuation methodologies and assumptions associated with the covered companies or price targets. Any assumptions made in this report that
refers to commodities, are for the purposes of making forecasts for the company (or companies) mentioned herein. They are not to be construed as
recommendations to trade in the physical commodity or in the futures contract relating to the commodity referred to in this report.
DBSVUSA, a US-registered broker-dealer, does not have its own investment banking or research department, has not participated in any public offering
of securities as a manager or co-manager or in any other investment banking transaction in the past twelve months and does not engage in market-
making.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of which the analyst, his spouse,
minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person accustomed or obliged to act in accordance with the directions
or instructions of the analyst.
2
Financial interest is defined as interest that are commonly known financial interest, such as investment in the securities in respect of an issuer or a new listing applicant, or
financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term does not include commercial lending conducted at the
arm’s length, or investments in any collective investment scheme other than an issuer or new listing applicant notwithstanding the fact that the scheme has investments in
securities in respect of an issuer or a new listing applicant.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
1. EGFSL, its subsidiaries and/or other affiliates do not have a proprietary position in the securities recommended in this report as of June 12, 2018
2. EGFSL, and/or Research Analyst does not market make in equity securities of the issuer(s) or company(ies) mentioned in this Research Report
Disclosure of previous investment recommendation produced:
3. EGFSL may have published other investment recommendations in respect of the same securities / instruments recommended in this research
report during the preceding 12 months. Please contact the primary analyst listed in the first page of this report to view previous investment
recommendations published by EGFSL in the preceding 12 months.
4. EGFSL , its subsidiaries and/or other affiliates and Research Analyst or his/her relative’s does not have any material conflict of interest in the
securities recommended in this report as of June 12, 2018.
5. EGFSL, its subsidiaries and/or other affiliates and Research Analyst or his/her relative’s does not have actual/beneficial ownership of 1% or more
securities of the subject company at the end of the month immediately preceding the June 12, 2018
6. EGFSL, its subsidiaries and/or other affiliates and Research Analyst have not received any compensation in whatever form including
compensation for investment banking or merchant banking or brokerage services or for products or services other than investment banking or
merchant banking or brokerage services from securities recommended in this report (subject company) in the past 12 months.
7. EGFSL, its subsidiaries and/or other affiliates and/or and Research Analyst have not received any compensation or other benefits from securities
recommended in this report (subject company) or third party in connection with the research report.
8. Securities recommended in this report (Subject Company) has not been client of EGFSL, its subsidiaries and/or other affiliates and/or and
Research Analyst during twelve months preceding the June 12, 2018
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
COMPANY-SPECIFIC / REGULATORY DISCLOSURES BY DBS BANK LTD AS DISTRIBUTOR OF THE RESEARCH REPORT
1. DBS Bank Ltd., DBS HK, DBS Vickers Securities (Singapore) Pte Ltd (“DBSVS”), DBSV HK or their subsidiaries and/or other affiliates do not have a
proprietary position in the securities recommended in this report as of 30 Apr 2018.
2. Neither DBS Bank Ltd, DBS HK nor DBSV HK market makes in equity securities of the issuer(s) or company(ies) mentioned in this Research Report.
RESTRICTIONS ON DISTRIBUTION
General This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or
located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be
contrary to law or regulation.
Australia This report is not for distribution into Australia.
Hong Kong This report is not for distribution into Hong Kong.
Indonesia This report is being distributed in Indonesia by PT DBS Vickers Sekuritas Indonesia.
Malaysia This report is not for distribution into Malaysia.
Singapore This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 16800306E) or DBSVS (Company Regn. No.
1860024G) both of which are Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary
Authority of Singapore. DBS Bank Ltd and/or DBSVS, may distribute reports produced by its respective foreign entities,
affiliates or other foreign research houses pursuant to an agreement under Regulation 32C of the financial Advisers
Regulations. Singapore recipients should contact DBS Bank Ltd at 6327 2288 for matters arising from, or in connection with
the report.
Thailand This report is being distributed in Thailand by DBS Vickers Securities (Thailand) Co Ltd.
United Kingdom This report is disseminated in the United Kingdom by DBS Vickers Securities (UK) Ltd, ("DBSVUK"). DBSVUK is authorised
and regulated by the Financial Conduct Authority in the United Kingdom.
In respect of the United Kingdom, this report is solely intended for the clients of DBSVUK, its respective connected and
associated corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any
form or by any means or (ii) redistributed without the prior written consent of DBSVUK. This communication is directed at
persons having professional experience in matters relating to investments. Any investment activity following from this
communication will only be engaged in with such persons. Persons who do not have professional experience in matters relating
to investments should not rely on this communication.
Dubai International This research report is being distributed by DBS Bank Ltd., (DIFC Branch) having its office at PO Box 506538, 3rd Floor,
Financial Centre Building 3, East Wing, Gate Precinct, Dubai International Financial Centre (DIFC), Dubai, United Arab Emirates. DBS Bank
Ltd., (DIFC Branch) is regulated by The Dubai Financial Services Authority. This research report is intended only for
professional clients (as defined in the DFSA rulebook) and no other person may act upon it.
United Arab Emirates This report is provided by DBS Bank Ltd (Company Regn. No. 196800306E) which is an Exempt Financial Adviser as defined
in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. This report is for information purposes
only and should not be relied upon or acted on by the recipient or considered as a solicitation or inducement to buy or sell any
financial product. It does not constitute a personal recommendation or take into account the particular investment objectives,
financial situation, or needs of individual clients. You should contact your relationship manager or investment adviser if you
need advice on the merits of buying, selling or holding a particular investment. You should note that the information in this
report may be out of date and it is not represented or warranted to be accurate, timely or complete. This report or any portion
thereof may not be reprinted, sold or redistributed without our written consent.
United States DBSVUSA did not participate in its preparation. The research analyst(s) named on this report are not registered as research
analysts with FINRA and are not associated persons of DBSVUSA. The research analyst(s) are not subject to FINRA Rule
2241 restrictions on analyst compensation, communications with a subject company, public appearances and trading securities
held by a research analyst. This report is being distributed in the United States by DBSVUSA, which accepts responsibility for
its contents. This report may only be distributed to Major U.S. Institutional Investors (as defined in SEC Rule 15a-6) and to
such other institutional investors and qualified persons as DBSVUSA may authorize. Any U.S. person receiving this report
who wishes to effect transactions in any securities referred to herein should contact DBSVUSA directly and not its affiliate.
In any other jurisdictions, except if otherwise restricted by laws or regulations, this report is intended only for qualified,
Other jurisdictions
professional, institutional or sophisticated investors as defined in the laws and regulations of such jurisdictions.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
SINGAPORE
DBS Bank Ltd
Contact: Janice Chua
12 Marina Boulevard, Marina Bay Financial Centre Tower 3
Singapore 018982
Tel. 65-6878 8888
Fax: 65 65353 418
e-mail: equityresearch@dbs.com
Company Regn. No. 196800306E
THAILAND
DBS Vickers Securities (Thailand) Co Ltd
Contact: Chanpen Sirithanarattanakul
989 Siam Piwat Tower Building,
9th, 14th-15th Floor
Rama 1 Road, Pathumwan,
Nagkok Thailand 10330
Tel. 66 2 857 7831
Fax: 66 2 658 1269
e-mail: research@th.dbs.com
Company Regn. No 0105539127012
Securities and Exchange Commission, Thailand
INDONESIA
PT DBS Vickers Sekuritas (Indonesia)
Contact: Maynard Priajaya Arif
DBS Bank Tower
Ciputra World 1, 32/F
JI. Prof. Dr. Satrio Kav. 3-5
Jakarta 12940, Indonesia
Tel. 62 21 3003 4900
Fax: 62 21 3003 4943
e-mail: research@id.dbsvickers.com
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore
Jignesh Shial, CA
jignesh.shial@emkayglobal.com
+91-22-66242468
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. DBS Bank Ltd, DBS Vickers Securities (Singapore) Pte Ltd,its respective connected and associated corporations and affiliates are the distributors of the research reports, please refer to the
last page of the report on Restrictions on Distribution. In Singapore, this research report or research analyses may only be distributed to Institutional Investors,Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore